Wednesday, March 26, 2025
HomeVenture Capital

Venture Capital

Venture Capital

Turn Therapeutics Secures $75 Million Investment Commitment Tied to Public Listing

Life Sciences Times - 0
Venture Capital

Syncell Announces $15 Million Series A Funding

Life Sciences Times - 0
Venture Capital

OpenClinica Acquires BuildClinical

Life Sciences Times - 0
Venture Capital

Tasca Therapeutics Launches with $52 Million Series A Financing

Life Sciences Times - 0
Venture Capital

Myomo, Inc. Prices $15.0 Million Public Offering of Common Stock

Life Sciences Times - 0
Venture Capital

IMPLANET Announces Financing of Around €2 Million

Life Sciences Times - 0
Venture Capital

Aya Healthcare to Acquire Cross Country Healthcare for Approximately $615 Million in Cash

Life Sciences Times - 0
Venture Capital

TRIO Pharmaceuticals Completes $3.1 Million Financing Round to Advance Cancer Therapeutics Pipeline

Life Sciences Times - 0
Venture Capital

H.B. Fuller Acquires Medifill Ltd.; Signs Provisional Agreement to Acquire GEM S.r.l.

Life Sciences Times - 0
Medtech

Niterra Ventures Company Invests $18M Additional Funding in Neoplas Med GmbH

Life Sciences Times - 0
Venture Capital

Enveda Closes $130M Series C Funding to Deliver Multiple Clinical Readouts from a Pipeline of 10 Development Candidates

Life Sciences Times - 0
Venture Capital

Henry Schein to Acquire Acentus, a Leading Supplier of Homecare Medical Products

Life Sciences Times - 0
1234...95Page 3 of 95

Most Read

EDITOR PICKS

THIS WEEK'S STORIES

POPULAR CATEGORY

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Contact us: [email protected]

FOLLOW US

© Newspaper WordPress Theme by TagDiv